title: Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors.
authors.forename: T
authors.initials: T
authors.lastname: Pollmächer
authors.forename: D
authors.initials: D
authors.lastname: Hinze-Selch
authors.forename: J
authors.initials: J
authors.lastname: Mullington
authors.forename: F
authors.initials: F
authors.lastname: Holsboer
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced; D003024:Clozapine / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006220:Haloperidol / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011446:Prospective Studies; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D012307:Risk Factors; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy
chemical_list: D015375:Receptors, Interleukin-2; D003024:Clozapine; D006220:Haloperidol